Judge certifies Johnson & Johnson shareholder class action over talc disclosures
J&J shareholders may pursue class action in lawsuit accusing company of concealing contamination talc products
A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.
U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013, to Dec. 13, 2018, to pursue their securities fraud claims as a group.
He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no "new" information.
Bottles of Johnson's baby powder line a drugstore shelf. (REUTERS/Lucas Jackson / Reuters Photos)
J&J's talc products have included its signature baby powder. The company stopped selling talc-based baby powder globally this year, switching to corn starch as the main ingredient. It has said its talc products are safe and do not contain asbestos.
SHEIN SUED BY RIVAL TEMU FOR ‘MAFIA-STYLE INTIMIDATION’
"Johnson & Johnson always strives to provide truthful and fulsome disclosures," Erik Haas, J&J's worldwide vice president of litigation, said in a statement. "We will continue to vigorously litigate cases that challenge the safety of our product or the accuracy of our public statements."
Lawyers for shareholders including the lead plaintiff San Diego County Employees Retirement Association did not immediately respond to requests for comment.
Class actions make it easier for shareholders to recover more money, at lower cost, than if they sued individually. A longer class period could increase the amount recovered.
The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock Exchange on July 12, 2021. ((AP Photo/Richard Drew, file) / AP Newsroom)
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 155.50 | +2.39 | +1.56% |
Johnson & Johnson
Shareholders said J&J's stock price fell six times in late 2017 and 2018 following events that confirmed how the New Brunswick, New Jersey-based company and various executives hid the truth about asbestos in its talc products.
These events included a jury awarding $4.69 billion in July 2018 to 22 women who said asbestos caused them to develop ovarian cancer, and a Reuters report five months later that said J&J knew about the asbestos risks for decades.
J&J said the six events could not have hurt its stock price because none contained new information that "corrected" its earlier disclosures.
It said the only new information from the verdict was that jurors accepted the women's arguments, and that all 56 internal documents mentioned in the Reuters report were already public.
A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. (REUTERS/Mike Blake / Reuters Photos)
Quraishi was unpersuaded. Addressing the Reuters report, he said its "careful analysis" and providing of "necessary context" made it more than a rehash of "stale information."
The share price fell 10% the day the report was released.
J&J also faces mass tort litigation encompassing more than 50,000 lawsuits over its talc products.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Courts have rejected two efforts by the company to use the bankruptcy process to limit its exposure to talc litigation.
The case is Hall v Johnson & Johnson et al, U.S. District Court, District of New Jersey, No. 18-01833.